Key result
Alpha-interferon was utilized in the clinical management of an infant with cavernous haemangioma complicated by Kasabach-Merritt syndrome.
Reports on the management of an infant with Kasabach-Merritt syndrome using alpha-interferon.
May support alpha-interferon consideration in Kasabach-Merritt syndrome; leaves open need for controlled trials.
A small number of patients with haemangioma need treatment for serious complications such as Kasabach-Merritt syndrome, cardiac failure and obstruction of the airway. We report on the management of an infant with Kasabach-Merritt syndrome.
No takes yet. Share an insight, caveat, or question.
Ettlinger et al. (1996) studied this question. Alpha-interferon was utilized in the clinical management of an infant with cavernous haemangioma complicated by Kasabach-Merritt syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: